Download PDF

Other users also viewed these articles

One-year retention rate of ixekizumab in patients with psoriatic arthritis and axial spondyloarthritis: Real-world data from the BIOBADASER registry Clementina López-Medina, Lucía Otero-Varela, Fernando Sánchez-Alonso, Vega Jovaní, Lorena Expósito-Pérez, Sheila Melchor-Díaz, Yanira Pérez-Vera, Paula Pretel-Ruiz, Javier Manero, Antonio Mera-Varela, Lourdes Mateo, Dolores Ruiz-Montesino, José Andrés Lorenzo-Martín, Teresa Pedraz-Penalva, Isabel Castrejón
10.1016/j.reumae.2025.501872
Anti-TNFα drug levels in patients with rheumatoid arthritis and spondyloarthritis Erardo Meriño-Ibarra, Francisco Javier Manero Ruíz
10.1016/j.reumae.2021.06.003
Development and feasibility of 4 checklists for the evaluation of comorbidity in patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis: GECOAI Project Santos Castañeda, Carlos González, Virginia Villaverde, Cristina Lajas Petisco, María Carmen Castro, Fernando Jirout, Juan Carlos Obaya, Juan Carlos Hermosa, Carmen Suárez, Silvia García, María Rodero, Leticia León, Amparo López Esteban, Milena Gobbo, Laly Alcaide, Juan Carlos Torre-Alonso
10.1016/j.reumae.2020.09.002